BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22887079)

  • 1. Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
    Milosevic JD; Puda A; Malcovati L; Berg T; Hofbauer M; Stukalov A; Klampfl T; Harutyunyan AS; Gisslinger H; Gisslinger B; Burjanivova T; Rumi E; Pietra D; Elena C; Vannucchi AM; Doubek M; Dvorakova D; Robesova B; Wieser R; Koller E; Suvajdzic N; Tomin D; Tosic N; Colinge J; Racil Z; Steurer M; Pavlovic S; Cazzola M; Kralovics R
    Am J Hematol; 2012 Nov; 87(11):1010-6. PubMed ID: 22887079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Yildiz M; Saiya-Cork K; Shedden K; Malek SN
    Clin Cancer Res; 2015 May; 21(9):2045-56. PubMed ID: 25652455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
    Tiu RV; Gondek LP; O'Keefe CL; Huh J; Sekeres MA; Elson P; McDevitt MA; Wang XF; Levis MJ; Karp JE; Advani AS; Maciejewski JP
    J Clin Oncol; 2009 Nov; 27(31):5219-26. PubMed ID: 19770377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms.
    Venton G; Courtier F; Charbonnier A; D'incan E; Saillard C; Mohty B; Mozziconacci MJ; Birnbaum D; Murati A; Vey N; Rey J
    Am J Hematol; 2018 Mar; 93(3):330-338. PubMed ID: 29148089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
    Sedeta E; Jemal A; Nisotel L; Sung H
    Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
    Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN
    Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.
    Stölzel F; Pfirrmann M; Aulitzky WE; Kaufmann M; Bodenstein H; Bornhäuser M; Röllig C; Kramer M; Mohr B; Oelschlägel U; Schmitz N; Soucek S; Thiede C; Ehninger G; Schaich M;
    Leukemia; 2011 Mar; 25(3):420-8. PubMed ID: 21135859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of interpreting genomic data in patients with acute myeloid leukemia.
    Nazha A; Zarzour A; Al-Issa K; Radivoyevitch T; Carraway HE; Hirsch CM; Przychodzen B; Patel BJ; Clemente M; Sanikommu SR; Kalaycio M; Maciejewski JP; Sekeres MA
    Blood Cancer J; 2016 Dec; 6(12):e510. PubMed ID: 27983727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
    Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
    Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
    Melody M; Kuykendall A; Sallman D; Al Ali N; Zhang L; Talati C; Padron E; Sweet K; Extermann M; List A; Lancet J; Komrokji R
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):312-315. PubMed ID: 32139296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
    Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.
    Martínez-Cuadrón D; Megías-Vericat JE; Serrano J; Martínez-Sánchez P; Rodríguez-Arbolí E; Gil C; Aguiar E; Bergua J; López-Lorenzo JL; Bernal T; Espadana A; Colorado M; Rodríguez-Medina C; López-Pavía M; Tormo M; Algarra L; Amigo ML; Sayas MJ; Labrador J; Rodríguez-Gutiérrez JI; Benavente C; Costilla-Barriga L; García-Boyero R; Lavilla-Rubira E; Vives S; Herrera P; García-Belmonte D; Herráez MM; Vasconcelos Esteves G; Gómez-Roncero MI; Cabello A; Bautista G; Balerdi A; Mariz J; Boluda B; Sanz MÁ; Montesinos P
    Blood Adv; 2022 Feb; 6(4):1278-1295. PubMed ID: 34794172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
    Gondek LP; Tiu R; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
    Blood; 2008 Feb; 111(3):1534-42. PubMed ID: 17954704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
    Heuser M; Gabdoulline R; Löffeld P; Dobbernack V; Kreimeyer H; Pankratz M; Flintrop M; Liebich A; Klesse S; Panagiota V; Stadler M; Wichmann M; Shahswar R; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Geffers R; Schlegelberger B; Göhring G; Kreipe HH; Germing U; Ganser A; Kröger N; Koenecke C; Thol F
    Ann Hematol; 2017 Aug; 96(8):1361-1372. PubMed ID: 28612220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML.
    Lalayanni C; Gavriilaki E; Athanasiadou A; Iskas M; Papathanasiou M; Marvaki A; Mpesikli S; Papaioannou G; Mallouri D; Batsis I; Papalexandri A; Sakellari I; Anagnostopoulos A
    Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):e233-e240. PubMed ID: 34756570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype.
    Ibáñez M; Such E; Onecha E; Gómez-Seguí I; Liquori A; Sellés J; Hervás-Marín D; Barragán E; Ayala R; LLop M; López-Pavía M; Rapado I; Neef A; Sanjuan-Pla A; Sargas C; Gonzalez-Romero E; Boluda-Navarro M; Andreu R; Senent L; Montesinos P; Martínez-López J; Angel Sanz M; Sanz G; Cervera J
    Sci Rep; 2020 Apr; 10(1):5904. PubMed ID: 32246042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.